China, which is reportedly selling Nepal vaccines against the coronavirus disease (Covid-19) at a price of $10 per dose, conveyed its displeasure with Kathmandu after some regional media publications disclosed the procurement price, reported news agency ANI on Sunday morning.
It was earlier reported that Nepal had had to sign a non-disclosure agreement with the makers of China’s Sinopharm Covid-19 vaccine in order to gain access to doses amid questions about the legality of such an undertaking.
Meanwhile, the disclosure of procurement price of China's Sinopharm vaccine in Sri Lanka sparked a row after reports emerged that Colombo had to shell out a higher per-dose price than its fellow South Asian country Bangladesh.
According to the Daily Mirror, Sri Lanka is paying $15 per dose for the Sinopharm vaccine, which is USD 5 higher than what Bangladesh paid.
Contrary to media reports, Channa Jayasumana, State Minister of Supply and Regulation of Pharmaceuticals, said there is "no such an agreement to give the vaccine at USD 10 for Bangladesh."
However, the State Minister's claims stand in contrast with what Bangladesh's Finance Minister AHM Mustafa Kamal, a Cabinet Division official, said in May that Bangladesh was purchasing the vaccine at USD 10 per dose.